The study aimed to test the effect of sweet basil extract on hypercholesterolemia. Sweet basil leaves were extracted with distilled water, ethanol and a mixture of distilled water: ethanol (1:3, v/v). Phenolic and flavonoids concentrates were fractionated and identified with High Performance Liquid Chromatograph (HPLC). Two levels of each concentrated extract were used to find its effect on the hypercholesterolemic rats. Six groups of hypercholesterolemic rats received 0.35 or 0.70 g/Kg bw from aqueous, ethanolic and aqueous + ethanolic extracts of sweet basil leaves and were compared with normal control group and hyperlipidemic control group for 30 days. Growth of rats, biochemical biomarks and histopathological examination were evaluated. Results showed that the main phenolic compound was pHydroxybenzoic acid. Meanwhile, the main flavonoids compound was rutin. The biological experiment showed that second concentration of sweet basil leaves extracts (ASBL2, ESBL2 and AESBL2) had a positive effect to lower the weight of hypercholesterolemic rats. No significant difference was found in relative organs weight among all tested rat groups. Sweet basil leave extracts had a positive effect to decrease serum triglycerides, total cholesterol, LDLcholesterol and VLDL-cholesterol of HC rats. The Atherogenic index (Al) was decreased due to sweet basil leaves extracts treated rat groups compared to the hyperlipidemic rats group. Sweet basil leaves extracts may play a role in improving the activity of antioxidant enzymes and decrease the lipid peroxidation (malondialdehyde, MDA) and level of H202 in serum. The serum ALT, AST, ALP and y-GT activities of the second concentration (0.70 g/Kg bw) of sweet basil leaves extracts had no significant difference compared to NC rats group. There was no significant difference in serum uric acid, urea and creatinine among all tested rat groups received sweet basil leaves extracts and NC rats group except for HC rats group. No histopathological changes were observed in liver of rat groups received second concentration (0.70 g/Kg bw) of sweet basil leaves extracts. In conclusion, the obtained results suggest that sweet basil leaves extracts had an important role in lowering the hyperlipidemia in experimental animals especially the second concentration of sweet basil leaves extracts.
Introduction
Hypercholesterolemia plays an important role in atherosclerosis and related cardiovascular diseases (CVD).
Increased plasma levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL) and very low-density lipoprotein cholesterol (VLDL) as well as lowered levels of high-density lipoprotein cholesterol (HDL) have been identified as major risk factors in the development of hypercholesterolemia. A high-cholesterol dietary habit is known to play an important role in the induction of chronic diseases such as hypercholesterolemia and hepatic abnormalities (Hsu et al., 2010).
wave length detector (Agilant ,Germany) 1100, autosampler, quaternary pump degasser and column compartment. Analyses were performed with a C18 reverse phase packed stainless-steel column (Zorbax ODS 5 pm 4.6 x 250 mm).
HPLC method started with linear gradient at a flow rate of 1.0 ml / min with mobile phase of water / acetic acid (98: 2 v/v, solvent A) and methanol / acetonitril (50: 50, v/v, solvent B) , starting with 5 % B and increasing B to levels of 30% at 25 min, 40% at 35 min, 52% at 40 min, 70% at 50 min, 100% at 55 min. The initial conditions were re-established by 5 min wash in both solvents. All chromatograms were plotted at 2A • nm to estimated phenolic acids and at 330 nm for flavonoids. All components were identified and quantified by comparison of peak areas with external standards.
Animals and treatments:
48 adult male albino rats weighing 200 g ± 5g were obtained and housed in the Ophthalmology Research Institute, Giza, Egypt. The rats were kept under normal health laboratory conditions and fed basal diet for one week. Water and basal diet were provided ad libitum. After one week, the animals were divided into eight groups (each six rats) as follows: Group 1: Normal control (NC), received basal diet. The sweet basil leaves extracts were orally given to rats daily by using stomach tube. Rats were given free access to food and water for 30 days.
Preparation of hypercholesterolemic diet (HCD):
HCD consists of basal diet 81.8%, cholesterol 2%, lard 16% and cholic acid 0.2% (Hamafi et al., 2009).
Growth of rats:
The rats were weighed at zero time and twice a week, total feed intake of each rat was weighed and feed efficiency ratio was calculated as gain of rat weight / total feed intake, g. At the end of the experimental period, rats were weighed and sacrifice by diethyl ether. The carcasses were dissected. Liver was cut off, washed in saline solution (NaCI 0.09 %) and weighed. The liver weight percentage was calculated as follows (Weight of liver/ total body weight x 100).
Biochemical parameters assays:
At the end of the experimental period, blood samples were collected from the animals' eye plexuses. Each sample was divided into two patches the first one was collected into heparinized tubes to obtain the plasma and the second into a free coagulation dry clean centrifuge glass tube to prepare the serum. Blood samples were left for 15 min. at room temperature, and then the tubes were centrifugated for 15 min. at 3000 rpm and the clean supernatant serum samples were frozen at -20 °C until analysis.
Serum triglycerides, total cholesterol, HDL-cholesterol and LDL-cholesterol were determined by using the 
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The activity of superoxide dismutase (SOD) and catalase (CAT) of rats' blood plasma were estimated according to Marklund and Marklund (1974) Alanine aminotransferase (ALT; EC 2.6.1.2) and aspartate aminotransferase (AST; EC 2.6.1.1) activities were assayed by the method of Bergmeyer and Harder (1986). Alkaline phosphatase (ALP; EC 3.1.3.1) activity was measured at 405 nm by the formation of paranitrophenol from para-nitrophenylphosphate as a substrate using the method of Varley et al., (1980). Gamma -GT was measured according to the method described by Szasz (1969). Creatinine, urea and uric acid were determined by using the methods described by Larsen (1972), Patton and Crouch (1977) and Caraway (1955) .
Histopathological study: Tissue specimens from rats' liver were fixed in 10% neutral buffered formalin solution. The fixed specimens were trimmed, washed and dehydrated in ascending grades of alcohol, cleaned in xylene, embedded in paraffin then sectioned (4-6 micron) and stained with hematoxyline and eosin according to Bancroft et al., (1996) . The degree of hepatic injury was estimated using an ordinal scale modified from Palaa and Charbonneau (1994).
Statistical analysis: Each parameter was analyzed separately by using one-way analysis of variance (ANOVA). For determining differences between groups, Duncan test was used. All p values < 0.05 were considered significant. 
Results
Results of fractionation and determination of phenolic compounds by high performance liquid chromatography (HPLC) are presented in Table ( 1). The data illustrated the phenolic compounds of sweet basil leaves extracts contains pyrogallo, protocatchic acid, caffeic acid, rosmarinic acid, catechein, catechol, vanillic acid, ferulic acid, pHydroxybenzoic acid and caffeine acid. It could be noticed that there was a remarkable variation in the amount of phenolic compounds of different extracts due to the extraction method. p-Hydroxybenzoic acid showed the highest amount of phenolic compounds. Meanwhile, caffeine resulted in the lowest amount of phenolic compounds. Table ( 2) shows the flavonoids compounds of sweet basil leaves extracts. Rutin is considered the main compound of flavones. Quercitrin, kampferol, apigenin, naringenin and quercetin were found in the different extracts with a fair deference in amounts of these compounds. The data show a slight difference among different extracts of sweet basil leaves. Rutin flavonoids compound was found to be the highest value while quercetin was in traces. Table ( 3) show the initial weight, final weight, weight and relative weight of liver, heart and kidney among groups. There was a significant difference in final weight of rats among the tested groups. It could be noticed that the lowest weight in rat groups received ASBL2, ESBL2 and AESBL2. It means that concentration of sweet basil leaves extracts at 0.70 g/Kg body weight reduced the weight of hypercholesterolemic rats. Low concentration of sweet basil extracts decreased the weight of hypercholesterolemic rats by 10 %. There was no significant difference in relative weight of liver, heart, and kidney among rat groups received all extracts of sweet basil compared to the NC. In contrast, the HC rats group showed highest final weight, relative weight of liver, heart, and kidney. Table ( 4) shows the lipid profile of different groups' rats that received sweet basil leaves extracts. There was significant increase in all parameters rats fed hypercholesterolemic diet. Sweet basil extracts significantly decreased the measured parameters. The ASBL1, ESBL1 and AESBL1 rat groups had about 40 % less serum triglycerides HC rat groups. Meanwhile, the second concentration (0.70 g Kg/ bw) of sweet basil leaves extracts decreased serum triglycerides to 50 % and there was no significant deference among these extracts and NC. The same trend is noticed in serum total cholesterol, HDL-cholesterol, LDL-cholesterol, and VLDL-cholesterol. The Al was significantly different in rat groups that received ASBL2, ESBL2, AESBL2 compared to NC rats group. However, the Al in ASBL2 was considered the nearest rats group in the Al the NC. Al value decreased approximately 62.5 % in rat groups that received the first concentration of sweet basil leaves extracts (0.35 g/Kg bw). The HC rats group had the highest Al value. Table ( 5) illustrated serum SOD, catalase, GST, GP", MDA and H202 of rats in various sweet basil leaves extracts treatment groups. The data clear that the hypercholesterolemic diet had a negative effect on the activity of antioxidant enzymes. There was a significant decreased in serum SOD, catalase and GPx activities of rats fed on HC diet. In contrast, the level of MDA, hydrogen peroxide (H2O2) and the activity of GST had significantly increased in rats fed on HC diet. Sweet basil leaves extracts improved the negative effect of HC diet. Concerning to the ASBL1, ESBL1 and AESBL1 rat groups, there were significant increase in serum SOD, catalase and GPx activities (72, 78 and 71% respectively) compared to HC rats group. In the ASBL2, ESBL2 and AESBL2 rat groups a positive increase in serum SOD, catalase and GP" activities was observed. There was no significant difference in the level of MDA, hydrogen peroxide (H2O2) and the activity of GST among rat groups received ASBL2, ESBL2 and AESBL2 and NC.
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The liver function tests of the tested rat groups are shown in Table ( 6) . There was significant increase in liver function tests in HC rats group compared to all rat groups and NC rats group. The serum ALT, AST, ALP and y-GT activities of the second concentration (0.70 g/Kg bw) of sweet basil leaves extracts had no significant difference compared to NC rats group. Moreover, the first concentration (0.35 g/Kg bw) of sweet basil leaves extracts had a significant decrease of serum ALT, AST, ALP and y-GT activities compared to HC rats group.
Data of the kidney function tests ( Table 7 ) revealed clearly that hypercholesterolemic diet had a negative effect on serum uric acid, urea and creatinine of tested rats. There was no significant difference among all tested rat groups received sweet basil leaves extracts and NC rats group.
Histopathological examination of liver ( Fig. 1) showed no apparent histopathological changes in liver of NC rats group no (Slidel ). Meanwhile, liver of HC rats group revealed cytoplasmic vacuolization of hepatocytes (Slide 2). The liver of rats received ASBL1 illustrated cytoplasmic vacuolations of hepatocytes (Slide 3). However, the liver of rats received ESBL1 showed congestion of central veins and kupffer cells activation (Slide 5). There was kupffer cells activation in liver of rats which received AESBL1 (Slide 7). In contrast, the liver of rats that received ASBL2, ESBL2 and AESBL2 (0.7 g/kg b.w.) showed no histopathological changes (Slide 4, 6 and 8).
Discussion
Sweet basil is widely used in medicine in many countries because it has antioxidant compounds. Phenolic and flavonoid compounds help to protect and treat certain diseases. In the present study, data of the phenolic compounds in sweet basil leaves extracts are in agreement with those observed by In the present study, the HC rat group had the highest final weight and relative weight of liver, heart, and kidney. Moreover, Basil leaf extract was highly effective in inhibiting carcinogen-induced tumor. Lee et al., (2005) showed that sweet basil had antioxidant activities because it had aroma constituents [3,7-dimethy1-1,6-octadien-3-ol (linalool; 3.94 mg/g), 1-methoxy-4-(2-propenyl) benzene (estragole; 2.03 mg/g), methyl cinnamate (1.28 mg/g), 4-ally1-2-methwyphenol (eugenol; 0.896 mg/g), and 1,8-cineole (0.288 mg/g). In the same trend, Juntachote et al. (2007) found that the supplementation of cooked ground pork with dried. Basil powder and its ethanolic extract significantly inhibited the formation of thiobarbituric acid-reactive substances (TBARS) and peroxide value.
Nakamura and
Our results show marked improvement in liver function of rats that received sweet basil leaves extracts compared to HC rats group. On the other hand, (Otunola et al., 2010) found that significant increase in the level of AST, ALT, ALP and GGT activities in rats fed with the hypercholesterolemic (HPC) diet for eight weeks. Moreover, Meera et al., (2009) found that the ethanolic extract of sweet basil (100 mg/Kg b.w.) returned the serum AST, ALT, ALP and GGT enzyme activities to the normal range for the goat treated with H202 or CCI4. Moreover, Sakr et al. (2011) showed that treating rats with CCI4 and aqueous leaves extract of sweet basil led to an improvement, in both histopathological and biochemical alterations induced by CCI4.
Creatinine is the major waste product of creatine metabolism. Free creatinine appears in blood serum. Urea and uric acid are the principal waste products of protein catabolism. Data in Table ( function. They found when the mice and old rats fed hypercholesterolemic diet (HCD), serum urea and creatinine were significantly increased and the percentage of increase was higher in old rat than mice. In the contract, Rasek et aL (2012) found that Ocimum Basilicum hydroalcoholic extract decreased the serum uric acid, urea and creatinine in wistar rats.
In conclusion, our results suggest that sweet basil leaves extracts had an important role in lowering the hyperlipidemia in blood especially the second concentration of sweet basil leaves extracts. In fact, flavonoids and tannins a heterogeneous group of ubiquitous plant polyphenols, have exhibited a variety of pharmacological activities, including the hypolipidemic effect. The possible mechanism underlying hypolipidemia of these phytochemicals results generally in three points: firstly these phenolic compounds increase hepatic LDL receptor activity ( 
